SCHEMBL28987476

SCHEMBL28987476

COCCN(Cc1ccc(C(=O)O)c(OC)c1)C(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
ALDH1A1 P00352 3/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC2 Q92769 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
LPAR1 Q92633 5/20 0.39
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPT P10636 3/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NR1H4 Q96RI1 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25489056 0.90 HDAC1 (0.39) PPARGPPARAALDH1A1HDAC1HDAC3
SCHEMBL3113320 0.82 PPARG (0.49) PPARGPPARAALDH1A1MTNR1AMTNR1B
SCHEMBL16992104 0.81 HDAC3 (0.50) PPARGPPARAALDH1A1HDAC1HDAC3
SCHEMBL16991900 0.79 L3MBTL1 (0.47) PPARGPPARAHDAC1HDAC3HDAC2
SCHEMBL13984783 0.78 HDAC1 (0.49) ALDH1A1HDAC1HDAC3HDAC2NCOR2
SCHEMBL13166745 0.77 HDAC1 (0.45) ALDH1A1HDAC1HDAC3HDAC2NCOR2
SCHEMBL1800104 0.76 HDAC1 (0.44) PPARAHDAC1HDAC3HDAC2NCOR2
SCHEMBL3567836 0.75 RIPK1 (0.46) HDAC1HDAC3HDAC2NCOR2L3MBTL1
SCHEMBL19784426 0.75 ADRB2 (0.47) PPARGPPARA
SCHEMBL3014216 0.75 HDAC1 (0.47) ALDH1A1HDAC1HDAC3HDAC2NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115996927-A Pyrimido [5,4-d ] pyrimidine derivatives and combinations with adenosine receptor antagonists as ENT inhibitors for the treatment of cancer ITEOS比利时公司 2023-04-21 CN disclosed